英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
merus查看　merus　在百度字典中的解释百度英翻中〔查看〕
merus查看　merus　在Google字典中的解释Google英翻中〔查看〕
merus查看　merus　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • MerusCase - Technology for Attorneys
    No more bulky files lying around, and no more having to spend 15 minutes looking for a file: everything we need is easily accessible in Merus We have used other case management systems, but Merus is by far the best It is the most advanced case management system, and it’s very user friendly
  • Closing in on cancer | Merus
    At Merus, we know that time is of the essence Every day, we bring a sense of urgency and a passion to help patients, by working towards discovering and…
  • Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating . . .
    A wholly owned subsidiary of Genmab (“Purchaser”) will commence a tender offer for 100% of Merus’ common shares, which is anticipated to close by early in the first quarter of 2026
  • Genmab pays $8B to buy Merus and phase 3-stage bispecific
    Genmab is continuing to build up its pipeline of wholly owned late-stage cancer assets, this time paying $8 billion for Netherlands-based Merus and its bispecific antibody
  • Merus (MRUS) Stock Price Overview
    Get the latest Merus N V (MRUS) stock price with news, financials and other important investing information
  • Merus N. V. - LinkedIn
    Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients Our most advanced development programs use the Biclonics® format Biclonics® are capable of
  • 10-K - SEC. gov
    In January 2022, we announced that Incyte elected to opt-out of its ex-U S development of MCLA-145, restoring full global rights to Merus Under the terms of the Incyte Collaboration Agreement, Incyte supported the program for a limited time while ex-U S activities transitioned to Merus
  • Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus
    Genmab (GMAB), on Monday, announced its plan to buy cancer-focused biotech company Merus (MRUS) for about $8 billion The news sent Merus stock into the stratosphere
  • ASCO 25: Merus bispecific scores again in HNSCC
    The drug showed efficacy in patients with both HPV-positive and HPV-negative disease, according to Netherlands-based Merus
  • Merus Stock Soars To All-Time High As Genmab Announces $8B Takeover . . .
    Merus NV’s stock climbed to a record high on Monday after Genmab said it would acquire the company in an $8 billion all-cash transaction, despite a broad wave of analyst downgrades Shares of Merus jumped 36% to close at $93 70 on Monday, before edging up 0 1%, in after-hours trading





中文字典-英文字典  2005-2009